Contribution of Cow's Milk to Iodine and Selenium Status in Women of Child-bearing Age (SIMI)

May 6, 2016 updated by: University of Ulster

Iodine is an essential trace element necessary for the synthesis of thyroid hormones which are critical for human growth and development throughout the lifecycle. Iodine is particularly important during pregnancy and infancy for brain and neurological development. Severe iodine deficiency during pregnancy can cause severe mental impairment and stillbirth while mild-to-moderate deficiency has been associated with impaired infant development. As such, pregnant women and women of child-bearing age are particularly vulnerable to the effects of iodine deficiency.

Globally, 241 million (30%) school aged children are iodine deficient. Historically, the UK and Ireland were believed to be iodine sufficient but concern has been expressed in the last decade regarding the iodine status of the UK and Irish populations. A study of Irish women in 2004 reported 55% of pregnant women in their sample population to be moderately iodine deficient and 53% of non-pregnant women to be moderately iodine deficient. A study of UK schoolgirls found that 51% were mildly iodine deficient and 16% were moderately deficient. Importantly, the prevalence of iodine deficiency was highest in Northern Ireland where 85% of those sampled were iodine deficient.

Iodine is known to interact with selenium in the conversion of the thyroid hormone thyroxine (T4) to the metabolically active triiodothyonine (T3) hormone. Selenium is also important for immune, cardiovascular and cognitive function. Selenium status has been reported to be moderately low using pooled English data on blood selenium concentrations from 1984 to 1992. In addition, the latest National Diet and Nutrition Survey reports that selenium intakes are below recommendations for several population groups including women of childbearing age where mean selenium intakes are 76% of the recommended 60µg/day. This national survey also reported that 49% of women aged 19-64 years failed to meet the lower reference nutrient intake of 40µg/day.

Milk and dairy products are the major source of iodine for the UK population and are also a source of selenium. The contribution of milk and dairy products to iodine and selenium intakes is greatest in adult females (35% and 6% respectively). Observational evidence has repeatedly reported milk consumption to be positively correlated with iodine status and iodine intakes. Research in Iceland and New Zealand has reported that milk consumption is not associated with selenium status; however it is unknown if this is true for the UK population.

To date, no randomised controlled trial has examined the effect of milk consumption on either iodine or selenium status. The possibility of increasing iodine and selenium intake by increasing milk consumption, a widely available and consumed foodstuff, in a population group vulnerable to micronutrient deficiency should be investigated. This would add valuable data to the knowledge base for iodine, where there is ongoing debate over the most appropriate means of increasing iodine intake amongst women of childbearing age in the UK where salt iodisation, the key strategy in preventing deficiency, is not implemented.

The aim of this study is to investigate the impact of cow's milk consumption on the biological status of iodine and selenium among women of child-bearing age.

The study will be a 12 week randomised-controlled human intervention study. Participants will be randomised to consume additional semi-skimmed milk in the Following amounts, control group (0mls/day), intervention group (430mls/day or 3l per week).

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

78

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Co.Londonderry
      • Coleraine, Co.Londonderry, United Kingdom, BT52 1SA
        • Human Intervention Studies Unit, Ulster University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Inclusion criteria
  • Healthy
  • Age 18-45 years
  • Females
  • Non smoking
  • No history of thyroid or gastrointestinal conditions
  • Not consuming thyroid medication or medication containing iodine or selenium
  • Willing to increase their milk consumption should they be randomised into the milk group

Exclusion Criteria:

  • Smoker
  • Pregnant, breastfeeding or planning to become pregnant during the study
  • Milk allergy
  • Non-milk consumers or vegans
  • Lactose intolerant individuals
  • Use of dietary supplements containing iodine or selenium in previous 3 months
  • Peri- or post-menopausal
  • Consume more than 250ml of milk daily

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Milk treatment group
Semi-skimmed cow's milk + normal diet for 12 weeks
430ml of semi-skimmed cow's milk / day for 12 weeks
No Intervention: Control group
Normal diet for 12 weeks

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Urinary iodine concentration
Time Frame: Change from baseline following 12-week intervention
Change from baseline following 12-week intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Serum thyroid hormone analysis
Time Frame: Baseline (week 0), mid (week 6) and post-intervention (week 12)
Baseline (week 0), mid (week 6) and post-intervention (week 12)
Urinary creatinine analysis
Time Frame: Baseline (week 0), mid (week 6) and post-intervention (week 12)
Baseline (week 0), mid (week 6) and post-intervention (week 12)
Serum selenoprotein P analysis
Time Frame: Baseline (week 0), mid (week 6) and post-intervention (week 12)
Baseline (week 0), mid (week 6) and post-intervention (week 12)
Dietary iodine and selenium intake
Time Frame: Baseline (week 0), mid (week 6) and post-intervention (week 12)
24-hour dietary recall
Baseline (week 0), mid (week 6) and post-intervention (week 12)
Blood pressure
Time Frame: Baseline (week 0), mid (week 6) and post-intervention (week 12)
Baseline (week 0), mid (week 6) and post-intervention (week 12)
Body Mass Index
Time Frame: Baseline (week 0), mid (week 6) and post-intervention (week 12)
Baseline (week 0), mid (week 6) and post-intervention (week 12)
Waist Hip ratio
Time Frame: Baseline (week 0), mid (week 6) and post-intervention (week 12)
Baseline (week 0), mid (week 6) and post-intervention (week 12)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2015

Primary Completion (Actual)

December 1, 2015

Study Completion (Actual)

December 1, 2015

Study Registration Dates

First Submitted

May 4, 2016

First Submitted That Met QC Criteria

May 6, 2016

First Posted (Estimate)

May 10, 2016

Study Record Updates

Last Update Posted (Estimate)

May 10, 2016

Last Update Submitted That Met QC Criteria

May 6, 2016

Last Verified

April 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • REC/15/0042

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Selenium and Iodine Status

Clinical Trials on Semi-skimmed cow's milk

3
Subscribe